Abstracts tagged "arthritis management"

Abstract Number: 1495 • 2015 ACR/ARHP Annual Meeting
Person-Centred Care Can Help Patients to Become More Effective Consumers in the Use of Health Information Than Regular Care – an RCT in Patients with Arthritis Undergoing Biological Therapy
Ingrid Larsson^1,2, Stefan Bergman^2,3,4 and Ann Bremander^2,3,5, ¹School of Health and Welfare, Halmstad University, Halmstad, Sweden, ²FoU Spenshult, Halmstad, Sweden, ³Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, ⁴Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ⁵School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden
Background/Purpose: Person-centred care (PCC) is a holistic approach with respectful and individualized care allowing negotiation of care where persons with health problems are empowered to…
Abstract Number: 2386 • 2015 ACR/ARHP Annual Meeting
Integrating Wearable Physical Activity Monitoring Tools into Rehabilitation Practice for Patients with Arthritis: The Healthcare Professional Perspective
Graham Macdonald¹, Jenny Leese², Catherine Backman³, Aileen Davis⁴, Anne F. Townsend⁵, J Antonio Avina-Zubieta⁶, Diane Gromala⁷ and Linda Li⁵, ¹Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, ²Rehabilitation Sciences, University of British Columbia, Vancouver, BC, Canada, ³Occup Science & OccupTherapy, University of British Columbia, Vancouver, BC, Canada, ⁴Health Care and Outcomes Rsrch, Toronto Western Research Institute, Toronto, ON, Canada, ⁵Arthritis Research Canada, Richmond, BC, Canada, ⁶Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁷Simon Fraser University, Vancouver, BC, Canada
Background/Purpose: Wearable physical activity monitoring tools can be used for goal-setting and progress-monitoring in rehabilitation programs for patients with arthritis. Little is known about the…
Abstract Number: 2496 • 2015 ACR/ARHP Annual Meeting
Telerheumatology: A Technology Not Appropriate for All
Zsolt Kulcsar^1,2, Daniel Albert³, Ellyn Ercolano⁴ and John Mecchella⁵, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Rheumatology/Leadership Preventive Medicine Residency, Dartmouth Hitchcock Medical Center, lebanon, NH, ³Medicine/Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, ⁴Telehealth, Dartmouth Hitchcock Center For Telehealth, Lebanon, NH, ⁵Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Title: Telerheumatology: A Technology Not Appropriate For AllBackground/Purpose: Access to Rheumatology care in New Hampshire (NH) and Vermont (VT) is limited, as a large proportion…
Abstract Number: 2524 • 2015 ACR/ARHP Annual Meeting
Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
Rossella Reggia¹, Laura Andreoli¹, Chiara Bazzani¹, Maria Grazia Lazzaroni¹, Giovanna Mazza¹, Michele Agosti¹, Roberto Gorla², Marco Taglietti², Andrea Lojacono³, Mario Motta⁴ and Angela Tincani⁵, ¹Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, ²Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, ³Obstetrics and Gynecology, Spedali Civili and University of Brescia, Brescia, Italy, ⁴Neonatal Intensive Care Unit, University and Spedali Civili of Brescia, Brescia, Italy, ⁵Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, Italy
Background/Purpose: Anti-TNFalfa agents have been used to control disease activity of patients with Chronic Arthritides (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis) during the wash-out period…
Abstract Number: 2565 • 2015 ACR/ARHP Annual Meeting
ACPA Specific IVIG Attenuate Collagen Induced Arthritis in Mice
Shaye Kivity¹, Nina Svetliscky¹, Qusim Odeh¹, Smadar Gertel¹, Howard Amital¹, Omer Gendelman¹, Iris Barshack², Alexander Volkov², Eran Bar-Meir³, Miri Blank¹ and Yehuda Shoenfeld⁴, ¹Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, ²Sheba Medical Center, Institute of Pathology, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, ³Plastic surgeon Poria Medical Center affiliated to Faculty of medicine in the Galilee Bar-Ilan university, Poria, Israel, ⁴Sheba Medical Center, Zabludowicz Center for Autoimmune Diseases, affiliated to affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel
Background/Purpose: Administration of intravenous-immunoglobulin (IVIg) is a recognized safe and efficient immunomodulatore therapy for many autoimmune diseases. Anti-idiotypic antibody binding to pathogenic autoantibodies was proposed…
Abstract Number: 2218 • 2013 ACR/ARHP Annual Meeting
Gingival Stem Cells Suppress Osteoclast Formation and Bone Erosion In CIA Through CD39 Signal
Song Guo Zheng¹, Jian Gu², Maogeng Chen¹ and Yi Shen³, ¹Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, ²Medcine, University of Southern California Keck School of Medicine, Los Angeles, CA, ³Medicine, Shanghai East Hospital at Tongji University, Shanghai, China
Background/Purpose: We recently have reported that human-derived gingival mesenchymal stem cells (GMSC) have strong capacity to suppress immune responses and T cell-mediated collagen-induced arthritis, however,…
Abstract Number: 2015 • 2013 ACR/ARHP Annual Meeting
Sarcoid Arthritis In World Trade Center Exposed New York City Firefighters Presenting As a Unique Clinical Subset
Konstantinos Loupasakis¹, Jessica Berman², Michelle S Glaser^3,4, Nadia Jaber⁴, Rachel Zeig-Owens^3,4, Mayris P Webber^4,5, Michael D Weiden^4,6, Anna Nolan^4,7, Kerry J Kelly⁴ and David J Prezant^4,8, ¹Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, ²Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, ³Medicine, Montefiore Medical Center, Bronx, NY, ⁴Bureau of Health Services Fire Department of New York, Brooklyn, NY, ⁵Medicine and Epideiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY, ⁶Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, ⁷Medicine, New York University School of Medicine, New York, NY, ⁸Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Sarcoidosis is a multisystem disease characterized by the formation of non-caseating granulomas with lungs being predominantly affected and the joints in up to 40%.…
Abstract Number: 1931 • 2013 ACR/ARHP Annual Meeting
Models Of Care For Arthritis: Drivers, Facilitators and Barriers To Their Development and Implementation
Aileen M. Davis¹, Cheryl Cott², Rose Wong³, Michel Landry⁴, Linda Li⁵, Allyson Jones⁶, Cy Frank⁷, Sydney C. Lineker⁸, Louise Bergeron⁹, Gillian A. Hawker¹⁰, Dianne P. Mosher¹¹, Vandana Ahluwalia¹², Michel Zummer¹³, Susan B. Jaglal¹⁴, Rhona McGlasson¹⁵, Richard Birtwhistle¹⁶, Sherry Bar¹⁷ and Elizabeth M. Badley¹⁸, ¹Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Ontario, ON, Canada, ²Divison of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ³Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, ⁴Department of Community and Family Medicine, Physical Therapy Division, Duke University Medical Center, Durham, NC, ⁵Arthritis Centre of Canada and Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, ⁶Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, ⁷Alberta Bone and Joint Institute and Department of Surgery, University of Calgary, Calgary, AB, Canada, ⁸The Arthritis Society, Toronto, ON, Canada, ⁹Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, ¹⁰Women's College Research Institute, University of Toronto, Toronto, ON, Canada, ¹¹Med, University of Calgary, Calgary, AB, Canada, ¹²Past President, Ontario Rheumatology Association, Brampton, ON, Canada, ¹³Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, ¹⁴Department of Physical Therapy, Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, ¹⁵Bone and Joint Canada, Toronto, ON, Canada, ¹⁶Centre for Studies in Primary Care and Family Medicine and Community Health and Epidemiology, Queen's University, Kingston, ON, Canada, ¹⁷British Columbia Ministry of Health Services, Victoria, BC, Canada, ¹⁸Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Management of arthritis is a growing concern given disease prevalence and limited health care resources. In the context of a larger project investigating innovative…
Abstract Number: 1586 • 2013 ACR/ARHP Annual Meeting
Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective
Elisabeth M.A Ball¹, Arthur Grey², Ai Lyn Tan³, Eiji Fukuba⁴, Gunter Steiner⁵, Dennis McGonagle⁶, Aubrey Bell⁷ and Madeleine Rooney⁸, ¹Rheumatology, Queens' University/Musgrave Park Hospital, Belfast, United Kingdom, ²Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, ³Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁴Department of Radiology, Shimane University, Izuma, Japan, ⁵Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ⁶NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ⁷Rheumatology Unit, Musgrave Park Hospital, Belfast, United Kingdom, ⁸Medicine, Queens University Belfast, Belfast, United Kingdom
Background/Purpose: Musculoskeletal involvement in systemic lupus erythematosus (SLE) is common but poorly characterised with only a few Magnetic Resonance Imaging (MRI) or ultrasound (US) studies…
Abstract Number: 1279 • 2013 ACR/ARHP Annual Meeting
Anti-IL-6 Receptor Antibody Is Effective In Arthritis Regardless Of Obesity In Mouse Model
Miho Suzuki, Hiroto Yoshida and Yoshihiro Matsumoto, Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan
Background/Purpose: Compared with non-obese patients, obese patients with rheumatoid arthritis (RA) reportedly experience worsening of symptoms [Arthritis Care Res (Hoboken). 2013; 65: 78-87] and do…
Abstract Number: 1139 • 2013 ACR/ARHP Annual Meeting
Pyogenic Arthritis: Clinical and Epidemiological Features Of 101 Cases At a University Hospital
Anne Riveros-Frutos¹, Lourdes Mateo¹, Melania Martínez-Morillo², Beatriz Tejera³, Samantha Rodriguez-Muguruza¹, Juana Sanint¹, Susana Holgado¹, Jerónima Cañellas¹, Xavier Tena¹, Alejandro Olivé¹ and Montserrat Gímenez⁴, ¹Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ²Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, ³Rheumatology, University Hospital of Canary Islands, Santa Cruz de Tenerife, Spain, ⁴Microbiology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain
Background/Purpose: To describe the clinical characteristics, treatment and outcome of patients diagnosed with pyogenic septic arthritis. Methods: Design: retrospective (1984-2012). Location: University hospital. Referial area:…
Abstract Number: 834 • 2013 ACR/ARHP Annual Meeting
Physical Activity Behavior In Patients With Arthritis
Gustavo J. Almeida¹ and Sara R. Piva², ¹Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ²Physical Therapy, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: : The physical activity (PA) guidelines issued by the US Health and Human Services (HHS) recommend that adults with arthritis should perform at least…
Abstract Number: 474 • 2013 ACR/ARHP Annual Meeting
HM-0523, a Novel Syk Inhibitor Significantly Ameliorates The Severity Of Arthritis In Rodents
Yu Cai¹, Zhong Cui Sun¹, Ping Ren¹, Lei Fang¹, Xiaoming Dai¹, Zhipeng Wu¹, Qianqian Dong², Xinrong Wang¹, Jian Wang¹, Yang Sai¹, Xiong Li¹ and Weiguo Su¹, ¹Hutchison Medipharma Limited, Shanghai, China, ²Inflammation & Immunology Research, Hutchison Medipharma Limited, Shanghai, China
Background/Purpose: Spleen tyrosine kinase (SYK) is a key mediator of signaling events downstream of a wide array of receptors important for immune function, including the…
Abstract Number: 338 • 2013 ACR/ARHP Annual Meeting
Tailored Approach To Early Psoriatic Arthritis Patients: Ultrasonographic Predictors For Structural Joint Damage
Yasser El Miedany¹, Maha El Gaafary², Sally Youssef³ and Annie Nasr⁴, ¹Rheumatology, Medway Hospital, Gillingham, United Kingdom, ²Community, Environmental and Occupational Medicine, Ain Shams University, Cairo, Egypt, ³Rheumatology & Rehabilitation, Ain Shams University, Cairo, Egypt, ⁴Radiology, Ain Shams University, Cairo, Egypt
Background/Purpose: To evaluate the use of musculoskeletal US as a predictor for inflammatory structural progression in psoriatic patients Methods: Measures of association (OR) were tested,…
Abstract Number: 2873 • 2013 ACR/ARHP Annual Meeting
The Ion Channel TRPV2 Is New Suppressor of Arthritis Severity and Joint Damage
Teresina Laragione^1,2, Max Brenner^1,2, Christine Beeton³ and Percio Gulko^1,2, ¹Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, ²Molecular Medicine, Hosftra North Shore-LIJ School of Medicine, Manhasset, NY, ³Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX
Background/Purpose: Rheumatoid arthritis (RA) is a common and chronic disease associated with increased risk of developing disability. Disease remission is still rarely achieved and better…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.